Jacquemin MG - Search Results

1

Factor VIII-Fc Activates Natural Killer Cells via Fc-Mediated Interactions With CD16.

Lagassé HAD, Hopkins LB, Jankowski W, Jacquemin MG, Sauna ZE, Golding B. Lagassé HAD, et al. Among authors: jacquemin mg. Front Immunol. 2021 Jun 28;12:692157. doi: 10.3389/fimmu.2021.692157. eCollection 2021. Front Immunol. 2021. PMID: 34262568 Free PMC article.

2

Anti-idiotypic antibodies: from regulation to therapy of factor VIII inhibitors.

Saint-Remy JM, Jacquemin MG, Gilles JG. Saint-Remy JM, et al. Among authors: jacquemin mg. Vox Sang. 1999;77 Suppl 1:21-4. doi: 10.1159/000056709. Vox Sang. 1999. PMID: 10529681 Review.

3

T cell response to FVIII.

Jacquemin M, Saint-Remy JM. Jacquemin M, et al. Cell Immunol. 2016 Mar;301:8-11. doi: 10.1016/j.cellimm.2015.09.007. Epub 2015 Sep 26. Cell Immunol. 2016. PMID: 26435345 Review.

4

Factor VIII inhibitors in previously treated haemophilia A patients with a double virus-inactivated plasma derived factor VIII concentrate.

Peerlinck K, Arnout J, Di Giambattista M, Gilles JG, Laub R, Jacquemin M, Saint-Remy JM, Vermylen J. Peerlinck K, et al. Thromb Haemost. 1997 Jan;77(1):80-6. Thromb Haemost. 1997. PMID: 9031454

5

Factor VIII inhibitors.

Gilles JG, Jacquemin MG, Saint-Remy JM. Gilles JG, et al. Among authors: jacquemin mg. Thromb Haemost. 1997 Jul;78(1):641-6. Thromb Haemost. 1997. PMID: 9198231 Review. No abstract available.

6

Mechanism and kinetics of factor VIII inactivation: study with an IgG4 monoclonal antibody derived from a hemophilia A patient with inhibitor.

Jacquemin MG, Desqueper BG, Benhida A, Vander Elst L, Hoylaerts MF, Bakkus M, Thielemans K, Arnout J, Peerlinck K, Gilles JG, Vermylen J, Saint-Remy JM. Jacquemin MG, et al. Blood. 1998 Jul 15;92(2):496-506. Blood. 1998. PMID: 9657749 Free article.

7

Antifactor VIII antibody inhibiting allogeneic but not autologous factor VIII in patients with mild hemophilia A.

Peerlinck K, Jacquemin MG, Arnout J, Hoylaerts MF, Gilles JG, Lavend'homme R, Johnson KM, Freson K, Scandella D, Saint-Remy JM, Vermylen J. Peerlinck K, et al. Among authors: jacquemin mg. Blood. 1999 Apr 1;93(7):2267-73. Blood. 1999. PMID: 10090936 Free article.

8

A human antibody directed to the factor VIII C1 domain inhibits factor VIII cofactor activity and binding to von Willebrand factor.

Jacquemin M, Benhida A, Peerlinck K, Desqueper B, Vander Elst L, Lavend'homme R, d'Oiron R, Schwaab R, Bakkus M, Thielemans K, Gilles JG, Vermylen J, Saint-Remy JM. Jacquemin M, et al. Blood. 2000 Jan 1;95(1):156-63. Blood. 2000. PMID: 10607698 Free article.

9

CD4+ T-cell clones specific for wild-type factor VIII: a molecular mechanism responsible for a higher incidence of inhibitor formation in mild/moderate hemophilia A.

Jacquemin M, Vantomme V, Buhot C, Lavend'homme R, Burny W, Demotte N, Chaux P, Peerlinck K, Vermylen J, Maillere B, van der Bruggen P, Saint-Remy JM. Jacquemin M, et al. Blood. 2003 Feb 15;101(4):1351-8. doi: 10.1182/blood-2002-05-1369. Epub 2002 Oct 17. Blood. 2003. PMID: 12393451 Free article.

10

CD4+CD25+ T cells lyse antigen-presenting B cells by Fas-Fas ligand interaction in an epitope-specific manner.

Janssens W, Carlier V, Wu B, VanderElst L, Jacquemin MG, Saint-Remy JM. Janssens W, et al. Among authors: jacquemin mg. J Immunol. 2003 Nov 1;171(9):4604-12. doi: 10.4049/jimmunol.171.9.4604. J Immunol. 2003. PMID: 14568934

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

107 results

Search Page